Search

Author/Creator Bertoletti, F

1. DOP78 Comparative study of the effectiveness of vedolizumab versus ustekinumab after anti-TNF failure (VERSUS-CD). (21st January 2022)

Authors:
García, M J; Rivero, M; Fernández-Clotet, A; de Francisco, R; Sicilia, B; Mesonero, F; de Castro, M L; Casanova, M J; Bertoletti, F; García Alonso, F J; López García, A; Julián, B; Calvet, X; Barreiro-de Acosta, M; Jara, L; Varela, P; Nuñez, A; Ricart, E; Riestra, S; Arias, L
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i121
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P104 Inflammatory complications of the pouch, and therapetic requirements after colectomy in patients with ulcerative colitis. Results from the RESERVO Study of GETECCU. (27th May 2021)

Authors:
Mesonero Gismero, F; Zabana, Y; Fernández-Clotet, A; Sola, A; Caballol, B; Leo, E; García, M J; Bertoletti, F; Alejandro, M; Suris, G; Casis, B; Ferreiro-Iglesias, R; Calafat, M; Jiménez, I; Miranda-Bautista, J; Lamuela, L J; Fajardo, I; Torrealba, L; Nájera, R; Sáiz, R M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S198
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P276 Influence of vedolizumab on extraintestinal manifestations in Inflammatory Bowel Disease: a nationwide multicenter study of the GETECCU Eneida registry. (27th May 2021)

Authors:
Pérez Galindo, P; Gisbert, J P; Carrillo-Palau, M; Bertoletti, F; González-Vivó, M; Ferrer, J A; Pajares, R; Merino, O; Castaño, A; Chaparro, M; Calvo, M; Barreiro-de-Acosta, M; Rodríguez, A; Lorente, R H; Algaba, A; Riado, D; Vela, M; De-la-Maza, S; Llaó, J; Vega, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S308
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P335 Impact of cancer therapy on the course of Inflammatory Bowel Disease (ONCOEII study of GETECCU). (30th January 2023)

Authors:
Pérez Galindo, P; Benítez, J M; Rubín de Célix, C; Mesonero, F; Castaño García, A; García, M J; Vicuña, M; Bernal, L; Bertoletti, F; Ramírez Castro, C; Sánchez-Azofra, M; Sánchez-Delgado, L; Ponferrada, Á; Tejido Sandoval, C; Capilla, M; Laredo de la Torre, V; Diz-Lois, M T; Dueñas Sadornil, C; G...
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i472
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P372 Effectiveness and safety of immunosuppressants for pouch disorders: results from the RESERVO Study of GETECCU. (27th May 2021)

Authors:
Mesonero Gismero, F; Zabana, Y; Fernández-Clotet, A; Leo, E; Caballol, B; Núñez, A; García, M J; Bertoletti, F; Mínguez, A; Suris, G; Casis, B; Ferreiro-Iglesias, R; Calafat, M; Jiménez, I; Miranda-Bautista, J; Lamuela, L J; Fajardo, I; Torrealba, L; Nájera, R; Sáiz, R M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S388
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P458 Effectiveness of biological therapy for pouchitis and other inflammatory complications ot the pouch. And the question of a second Anti-TNF after failure? Results from the RESERVO Study of GETECCU. (27th May 2021)

Authors:
Mesonero Gismero, F; Zabana, Y; Fernández-Clotet, A; Núñez, A; Caballol, B; Sola, A; García, M J; Bertoletti, F; Mínguez, A; Suris, G; Casis, B; Ferreiro-Iglesias, R; Calafat, M; Jiménez, I; Miranda-Bautista, J; Lamuela, L J; Fajardo, I; Torrealba, L; Nájera, R; Sáiz, R M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S451
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P531 SARS-CoV-2 infection in Elderly patients with Inflammatory Bowel Disease with or without immunosuppressants during the first year of the pandemic. An observational, descriptive, cohort study. (27th May 2021)

Authors:
Calafat Sard, M; González-Muñoza, C; Fortuny, M; Roig, C; Calm, A; Mombiela, A; Teller-Martin, M; Cañete, F; Bertoletti, F; González-González, L; Gordillo, J; Mañosa, M; Garcia-Planella, E; Domènech, E
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S506
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P559 Real-life experience with long-term maintenance of golimumab in ulcerative colitis patients. (25th January 2019)

Authors:
Iborra, M; García-Morales, N; Rubio, S; Nantes Castillejo, O; Bertoletti, F; García-Planella, E; Calvo, M; Vera, I; Taxonera, C; Alba, C; Boscá-Watts, M; Martí-Aguado, D; Ballester Ferrer, M P; Sierra, M; Cano-Sanz, N; Mancenido, N; Pajares-Villarroya, R; Beltrán, B; Cañada, A; Nos, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S393
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗